Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Buy of Genzyme Genetics Clears FTC

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said that its $925 million proposed acquisition of Genzyme Genetics has cleared antitrust review.

The Burlington, N.C.-based medical laboratory testing and services firm said that it has received early termination from the Federal Trade Commission of the waiting period under the federal Hart-Scott-Rodino Antitrust Improvement Act of 1976, clearing one hurdle for LabCorp to close the purchase of Genzyme Genetics on or around Dec. 1.

The deal is expected to have a net cash cost to LabCorp of about $795 million, after income tax benefits and acquisition-related costs have been factored in.

Genyzme Genetics, a business unit of Genzyme, performs more than 1.5 million clinical tests each year. In 2009, it generated about $371 million in revenues. The menu of services it provides includes maternal serum screening, prenatal diagnostics, carrier screening, and postnatal testing.

The sale of the business is part of a strategy by Genzyme to concentrate on its core business.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.